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Dabigatran is a new oral direct thrombin inhibitor and has been
proposed to overcome many pitfalls of warfarin therapy.
Method: In this study, we retrospectively studied 236 patients who
had atrial ﬁbrillation and were at risk of stroke who received ﬁxed
dose of Dabigatran 110 mg and adjusted-dose warfarin. Patients
were followed up for a period of 2 years and stroke or systemic
embolism was our primary end points.
Results: When rates of the primary outcome were considered
which was 1.56% per year in the warfarin group, as compared with
1.33% per year in the group that received 110 mg of dabigatran
(relative risk with dabigatran, 0.90; 95% conﬁdence interval [CI],
0.72–1.09; p < 0.001 for non inferiority). Again the rate of major
bleeding was 2.96% per year in the warfarin group, as compared
with 2.11% per year in the group receiving 110 mg of dabigatran
( p = 0.005). If the rate of hemorrhagic stroke was considered, it was
0.34% per year in the warfarin group, as compared with 0.09% per
year with 110 mg of dabigatran ( p < 0.003). Finally the mortality
rate was 3.9% per year in the warfarin group, as compared with
3.15% per year with 110 mg of dabigatran ( p = 0.11)
Conclusions:We observed in our study that, dabigatran given at a
dose of 110 mg was associated with rates of stroke and systemic
embolism that were similar and were non inferior to those asso-
ciated with warfarin, as well as lower rates of major hemorrhage.
Alsomany pitfalls of warfarinwere coveredwell by Dabigatran and
hence it's use in patients of atrial ﬁbrillation with risk of stroke can
be advocated.
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Inmicamineworkers in Nellore district the prevalence of ischemic
heart disease and serum cholesterol levels are less in when com-
pared to other rural population in our earlier studies. Vanadium
content of mica and Blood levels of vanadium in mica workers is
high compared to other rural population. Hence study in experi-
mental animals is under taken in our laboratory to know the effect
of vanadium.
Vanadium is an essential trace elements in certain animals and its
role in humans is debated. Under physiological conditions vana-
dium predominantly exists in either an anionic form (vanadate) or
a cationic form vanadyl. The vanadate is mainly bound to trans-
ferin and to a lesser extent to albumin. The present study aimed to
know the effect of vanadium supplementation on high fat diet
induced hyperlipidemia in experimental animals. In this study,
New Zealand white breed male rabbits divided into three groups
and each group consists of 6 in number.
Group I: Rabbits fed with standard diet.
Group II: Fed with 2% cholesterol diet.
Group III: Rabbits fed with group II diet and supplemented with
0.75 mg/kg of elemental vanadium as Sodium meta vanadate.
Total cholesterol, LDL cholesterol and triglycerides were signiﬁ-
cantly decreased in Group III when compared to Group II after the
experiment. HDL is similar in both groups. Present study shows
antilipedemic effect of Vanadium in experimental rabbits. Supple-
mentation of vanadiummay prevent cardiovascular risk factor like
Hyperlipidemia.
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Introduction: ST2 is a biomarker which is a member of the inter-
leukin (IL)-1 receptor family and exists in two forms, a trans-
membrane receptor (ST2L) as well as a soluble decoy receptor
(sST2). Myocytes that are subjected to mechanical stress secrete
ST2, that is associated with HF after STEMI.
Aims & objectives: To co-relate the level of ST2 on presentation
and at discharge, with the clinical severity of the disease on
presentation, the subsequent complications of ACS during the
hospital stay and the occurrence of heart failure/adverse cardio-
vascular events (re-infarction/death) after discharge.
Inclusion & exclusion criteria:
1. Age more than 30 years.
2. Presenting within 24 hours of onset of symptoms.
3. Fulﬁlling the criteria for diagnosis of Acute MI.
4. Patients with PCI related and CABG related acute MI have been
excluded.
Materials and methods: A prospective study is being done in
patients admitted with ACS in Apollo hospital Chennai. Blood
samples for ST2 are taken on presentation & at discharge. The
sample is analysed using the 'Presage kit' provided by Critical
diagnostics-Chennai Medipoint. A cut off of 35 ng/dl was used to
label a sample as high ST2 level. Clinical history, biochemical tests
and Echocardiography results are also documented.
Results: 42 patients admitted in Apollo Hospital, Chennai have
been included so far. The clinical proﬁle, ST2 levels, the clinical
outcome and re-hospitalisations (if any) were documented.
Conclusion: The study is still in process and concrete conclusions
cannot be drawn based on the existing samples. However high ST2
values were seen to be associated with increased mortality.
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Introduction: Cardiovascular (CV) involvement is common and a
signiﬁcant cause of morbidity and mortality in systemic lupus
erythematosus (SLE). Auto-antibodies anti-dsDNA and antipho-
spholipids antibodies (APLA) are both pathogenic as well as serve
a role as biomarker for diagnosis and severity. There are only very
few reports of correlation of anti-dsDNA and/or APLA positivity
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) s 1 2 1 – s 1 3 3 S125
